Singh, I.; Issar, T.; Poynten, A.M.; Milner, K.-L.; Krishnan, A.V.; Dhanapalaratnam, R.
Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes. Biomedicines 2024, 12, 2518.
https://doi.org/10.3390/biomedicines12112518
AMA Style
Singh I, Issar T, Poynten AM, Milner K-L, Krishnan AV, Dhanapalaratnam R.
Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes. Biomedicines. 2024; 12(11):2518.
https://doi.org/10.3390/biomedicines12112518
Chicago/Turabian Style
Singh, Indumathi, Tushar Issar, Ann M. Poynten, Kerry-Lee Milner, Arun V. Krishnan, and Roshan Dhanapalaratnam.
2024. "Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes" Biomedicines 12, no. 11: 2518.
https://doi.org/10.3390/biomedicines12112518
APA Style
Singh, I., Issar, T., Poynten, A. M., Milner, K.-L., Krishnan, A. V., & Dhanapalaratnam, R.
(2024). Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes. Biomedicines, 12(11), 2518.
https://doi.org/10.3390/biomedicines12112518
